Company

Raphael Pharmaceutical Inc. (RAPH)

Standardized SEC financial data for Raphael Pharmaceutical Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001415397 · OTC · Medicinal Chemicals & Botanical Products.

Return on equity

89.3%

Free cash flow

-$212K

Current ratio

0.03×

EPS (diluted)

$0.07

Income statement

USD	FY2021	FY2022	FY2022	FY2023	FY2024	FY2025
R&D expense	$776K	—	$1.2M	$569K	$776K	$631K
SG&A expense	$853K	—	$2.1M	$763K	$733K	$614K
Operating income	-$1.6M	—	-$3.3M	-$1.3M	-$1.5M	-$1.2M
Net income	-$1.6M	—

Standardized from Raphael Pharmaceutical Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Balance sheet

USD	FY2022	FY2023	FY2024	FY2025	FY2025	FY2025
Cash & equivalents	$288K	$230K	$19K	—	—	$45K
Accounts receivable	—	—	$2K	—	—	$2K
Total current assets	$331K	$237K	$25K	—	—

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$779K	-$1.4M	-$759K	-$1.2M	-$532K	-$210K
Capital expenditures	—	—	$2K	—	—	—
Free cash flow	—	—	-$761K	—	—

Get RAPH data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/RAPH/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/RAPH/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View RAPH filings on SEC EDGAR →